LGVNMICRO

Longeveron Inc.

HealthcareBiotechnology
$0.72
$0.00(-1.85%)
52W$0.47
$1.80
Updated Jun 28, 02:00 AM
RSI41
RS Rating46/99
Beta0.72
Volatility118%
F-Score2/9
Mkt Cap$16M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Longeveron Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 46), showing significant lag compared to the market leaders. Earnings growth of 44% provides fundamental context to the price action. Investors should exercise caution due to high volatility (118% annualized), which requires wider risk management.

Relative Strength
46
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.72
vs S&P 500
DEFENSIVE
52W Position
18%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.82
50 SMA > 100 SMA$0.80
100 SMA > 150 SMA$0.73
150 SMA > 200 SMA$0.75

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.77-7.61%BELOW
50 SMA$0.82-12.94%BELOW
100 SMA$0.80-11.08%BELOW
150 SMA$0.73-2.13%BELOW
200 SMA$0.75-4.11%BELOW

Price Performance

1D-1.9%
1W-10.6%
1M-14.0%
3M-26.5%
6M+34.2%
YTD+20.7%
1Y-45.0%
3Y-72.9%
52-Week Trading Range18% from low
$0.72
52W Low$0.47
52W High$1.80

Technical Indicators

RSI (14)NEUTRAL
40.7
305070
Setup ScoreCOOL
3/10
Base depth: 79.7%

Risk Profile

Beta
0.72
52W Vol
118%
ATR
$0.05
Max DD (1Y)
-72%

Volume Analysis

Today
50D Avg
329.4K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+82%
$-0.33
Q3'25-15%
$-0.39
Q4'25+11%
$-0.24
Q1'26+44%
$-0.19
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:-26.60%
3 Years:-0.63%
TTM:-45.35%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+58.63%

Stock Price CAGR

10 Years:-37.12%
5 Years:-61.10%
3 Years:-72.94%
1 Year:-44.96%

Return on Equity

10Y Avg:-107.5%
5Y Avg:-117.0%
3Y Avg:-144.5%
Last Year:-202.4%

Key Metrics

Market Cap$16M
Gross Margin67.0%
Net Margin-18.9%
Piotroski F-Score2/9

Frequently Asked Questions

Is LGVN in an uptrend right now?

LGVN has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is LGVN overbought or oversold?

LGVN's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.

Is LGVN outperforming the market?

LGVN has a Relative Strength (RS) Rating of 46 out of 99. LGVN is currently lagging the broader market.

Where is LGVN in its 52-week range?

LGVN is trading at $0.72, which is 40% of its 52-week high ($1.80) and 18% above its 52-week low ($0.47).

How volatile is LGVN?

LGVN has a Beta of 0.72 and 52-week volatility of 118%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.